Vassallo Steven sold $10.5M of CBRS (indirect holdings)

Vassallo Steven sold 50,000 indirectly-held shares of Cerebras Systems Inc. (CBRS) at an average of $210.30 ($209.81–$211.56, $10.52M total) across 3 trades on 2026-09-04.

Original reporting
SEC EDGAR · Vassallo Steven
Published Sep 9, 2026, 12:20 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 9, 2026, 12:34 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
MARKET
Neutral
AI market analysis
Mentioned
$CBRS
Relevance
7/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

Med
01

Why it matters

A director’s $10.5M share sale is a material event that can influence investor perception and short‑term price action.

02

Market read

The filing signals possible downside risk for CRSR and may prompt traders to reassess exposure.

03

What to watch

Potential tax‑loss harvesting or diversification needs of the director may drive the transaction.

Relevance 7/10Novelty 8/10Timing: filed Sep 8 2026, sale executed Sep 4 2026

Background

Form 4 filings provide the first public disclosure of insider transactions, offering timely insight into insider sentiment.

Market effects

May raise caution for AI‑hardware and semiconductor peers as insider activity is monitored.

Limited to US‑listed AI chip sector; no broader regional effect.

Low; impact confined to Cerebras and closely related AI compute stocks.

Counterpoint

The sale could be a routine portfolio rebalancing unrelated to company fundamentals.

Key entities

  • Cerebras Systems Inc.

    AI‑focused semiconductor company listed on NASDAQ (CRSR).

  • Steven Vassallo

    Director of Cerebras who executed the insider sale.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$CBRSMed

Cerebras (CBRS) Plants A 165 MW Flag In Finland While Still Losing Money

Cerebras Systems (CBRS) announced a new AI data center in Finland with partner Compute Nordic Finland, set to reach 165 MW capacity. The project is backed by contracts and will be built in stages. Cerebras reported a 281% increase in cloud revenue for the quarter, but still operates at a loss. The company raised its full-year outlook but expects lower margins in the third quarter. Hedge fund ownership increased significantly, while short interest remains high.

$CBRSHighAI 8/10

Cerebras Drops 19% in 3 Months: Buy, Sell or Hold the Stock?

Cerebras Systems (CBRS) shares fell 19% in 3 months due to profitability concerns, margin pressure, and competition. Q3 2026 revenue guidance is $214-$216M, with margins expected to decline. The company faces customer concentration risks and competition from NVIDIA, AMD, and Intel. Despite strong RPO and expansion plans, near-term challenges persist. Analysts see a 56.93% upside potential.

$CBRSMedAI 8/10

Cerebras Has a $25.4 Billion Backlog, and One OpenAI Agreement Is Behind Much of It

Cerebras Systems reported Q2 adjusted revenue of $209.9M, up 103% YoY, with a $25.4B backlog driven by an OpenAI agreement. The company raised its full-year outlook to $880M-$890M. OpenAI's deal accounts for most of the backlog, with revenue recognition expected over several years. Cerebras' stock is down 44% from its 52-week high, trading at a market cap of ~$51B.

$CBRSHighAI 8/10

CBRS Stock Surges 68% On Nasdaq Debut: Cathie Wood's ARK Buys Shares While Trimming TSMC, AMD

Cerebras Systems (CBRS) shares surged 68% on their Nasdaq debut, closing at $311.07, with a market cap of $95B. ARK ETFs bought 105,616 shares, while trimming stakes in TSMC and AMD. The IPO raised $5.6B, with strong demand highlighting investor interest in AI hardware. CBRS reported $510M in 2023 sales, up from $290.3M in 2024, and partners with OpenAI, Meta, AWS, and IBM.

$CBRSMed

CBRS Stock Slides As Cerebras Ramps AI Capacity And Growth

Cerebras Systems Inc. (CBRS) stock rose 10.73% on September 4, 2026, driven by investor optimism around AI chip adoption. The company reported Q2 2026 revenue of $510M and a loss of $451M, with a high price-to-sales multiple of 117x. Morgan Stanley reiterated its overweight rating, citing strong AI demand and partnerships. CBRS faces execution risks due to high spending on AI capacity expansion.